COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

Clinical trial NCT04498286 · COMPLETED

Trial details

NCT number: NCT04498286
Sponsor: Zoé van Kempen
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2020-08-08
Primary completion: 2021-10-31
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.